Endothelial dysfunction and its correction with perindopril therapy in patients with coronary heart disease

Endothelial dysfunction and its correction with perindopril therapy in patients with coronary heart disease

Aim. To investigate endothelial dysfunction (ED) in patients with coronary heart disease (CHD), stable effort angina, Functional Class (FC) I-III, as well as to study perindopril potential in ED correction.Material and methods. The study included 37 CHD patients (22 men, 15 women; mean age 62,2+5,3...

Full description

Bibliographic Details
Main Authors:	O. A. Vartanova, N. V. Mikhailova, T. E. Morozova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2008-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	ишемическая болезнь сердца эндотелиальная дисфункция периндоприл
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1378

Similar Items

Physical rehabilitation and endothelial dysfunction in coronary heart disease
by: V. A. Margazin, et al.
Published: (2006-02-01)

Clinical and pharmaco-economic assessment of ACE inhibitors perindopril and enalapril in coronary heart disease patients after coronary artery bypass graft surgery
by: Yu. M. Lopatin, et al.
Published: (2009-06-01)

Diagnostic assessment of endothelial function in metabolic syndrome and coronary heart disease
by: V. A. Nevzorova, et al.
Published: (2011-04-01)

Perindopril effects on circadian heart rate variability in patients with coronary heart disease and stable angina
by: N. A. Shardanov, et al.
Published: (2007-08-01)

Pharmacological correction of plasma redox potential and endothelial dysfunction in ischemic heart failure
by: O. P. Donetskaya, et al.
Published: (2012-02-01)

Endothelial dysfunction and prognosis after coronary interventions in patients with coronary heart disease and arterial hypertension
by: M. V. Kazak, et al.
Published: (2011-10-01)

Arterial endothelial dysfunction and its role for prognosis assessment in cardiovascular patients
by: G. N. Soboleva, et al.
Published: (2010-04-01)

НЕКОТОРЫЕ ПАРАМЕТРЫ АТЕРОГЕНЕЗА У БОЛЬНЫХ АНЕМИЯМИ
by: В. Г. Желобов, et al.
Published: (2014-12-01)

Combined antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: O. A. Ageenkova, et al.
Published: (2011-06-01)

PREMIERE study: reaching target blood pressure level – a success in coronary heart disease treatment
by: Yu. A. Karpov, et al.
Published: (2006-12-01)

Comparison of endothelial function in patients with Stage I-II arterial hypertension and stable angina, receiving various bradycardic agents and perindopril
by: L. L. Kirichenko, et al.
Published: (1970-01-01)

Modern aspects of angina treatment in arterial hypertension patients: emphasizing endothelial function role
by: L. L. Kirichenko, et al.
Published: (2008-04-01)

ENDOTHELIAL DYSFUNCTION IN STABLE ANGINA AND MYOCARDIAL INFARCTION COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: M. A. Popova, et al.
Published: (2015-12-01)

CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION
by: N. P. Lyamina, et al.
Published: (2015-12-01)

THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-09-01)

Acute nitroglycerin test for predicting perindopril therapy effectiveness in patients with coronary heart disease and chronic heart failure
by: I. G. Fomina, et al.
Published: (2005-12-01)

Erectile dysfunction and pcsychoemotional state in ischemic heart disease patients undergone coronary artery bypass grafting
by: Ye. V. Pomeshkin, et al.
Published: (2012-04-01)

NOVEL COMBINATION OF THE ANGIOTENSIN CONVERTING ENZYME INHIBITOR PERINDOPRIL AND HIGHLY SELECTIVE β-ADRENOBLOCKER BISOPROLOL: PRIME AMONG THE EQUAL
by: O. D. Ostroumova, et al.
Published: (2018-06-01)

ПРИМЕНЕНИЕ МЕТОДА ЭКСТРАКОРПОРАЛЬНОЙ АУТОГЕМОМАГНИТОТЕРАПИИ С ЦЕЛЬЮ КОРРЕКЦИИ ГЕМОДИНАМИЧЕСКИХ НАРУШЕНИЙ В ИНТРАОПЕРАЦИОННОМ ПЕРИОДЕ ПРИ ПРОВЕДЕНИИ КОРОНАРНОГО ШУНТИРОВАНИЯ В УСЛОВИЯХ ИСКУCСТВЕННОГО КРОВООБРАЩЕНИЯ
by: К. О. Кротков, et al.
Published: (2024-03-01)

Endothelial vasoactive mediators in young patients with minor heart anomalies
by: A. V. Yagoda, et al.
Published: (2007-06-01)

Pharmacological correction of pro- and anti-inflammatory cytokine induction and energy metabolism system state in patients with coronary heart disease and chronic heart failure
by: V. E. Malikov, et al.
Published: (2011-10-01)

Oxygen support of physical stress in perindopril-treated hypertensive patients
by: V. I. Makolkin, et al.
Published: (2005-12-01)

Right heart remodeling in coronary heat disease: clinico-pathophysiological correlations
by: N. S. Buslenko, et al.
Published: (2005-10-01)

Left and right ventricular diastolic dysfunction in patients with coronary heart disease and initial stages of chronic heart failure
by: Z. O. Georgadze, et al.
Published: (1970-01-01)

Noliprel and endothelial dysfunction correction in metabolic syndrome patients
by: V. V. Trusov, et al.
Published: (2005-12-01)

Результаты исследования EUROPA
Published: (2018-06-01)

Ivabradine potential for correcting myocardial electrical instability predictors in coronary heart disease
by: I. P. Tatarchenko, et al.
Published: (2008-12-01)

Dyslipidemia correction with atorvastatin in patients with coronary heart disease and arterial hypertension
by: N. B. Amirov, et al.
Published: (1970-01-01)

The specific features of the diagnosis and treatment of coronary heart disease in rheumatoid arthritis (Results of the authors’ studies)
by: Natalya Anatolyevna Khramtsova, et al.
Published: (2012-06-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

CONTEMPORARY APPROACHES TO ANTIPLATELET THERAPY IN CORONARY HEART DISEASE TREATMENT
by: S. T. Matskeplishvili, et al.
Published: (2014-08-01)

Clinical pharmacology of the combination of ACE inhibitors and calcium antagonists: benefits of the perindopril arginine and amlodipine combination
by: M. V. Leonova
Published: (1970-01-01)

Relationship between coronary artery calcification and osteopenic syndrome in men with coronary heart disease
by: T. A. Raskina, et al.
Published: (2016-06-01)

Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01)

Development of endothelial dysfunction at an obliterating atherosclerosis of vessels of the lower extremities and markers of prediction of a course of a disease
by: S. S. Dunaevskaya, et al.
Published: (2017-04-01)

Arterial stiffness and albuminuria as markers of endothelial dysfunction in those with chronic obstructive pulmonary disease
by: A. A. Bakina, et al.
Published: (2021-04-01)

CEREBROVASCULAR PATHOLOGY IN PATIENTS WITH CORONARY HEART DISEASE (NEROIMAGING RESULTS)
by: Irina Danilovna Syrova, et al.
Published: (2023-09-01)

OBSTRUCTIVE CORONARY ATHEROSCLEROSIS AND ISCHEMIC HEART DISEASE: AN ELUSIVE LINK!
by: M. Marzilli, et al.
Published: (2015-12-01)

Biomarker levels, left ventricular dysfunction, and severity of coronary pathology in elderly patients with coronary heart disease
by: L. R. Mirzakhanova, et al.
Published: (2012-10-01)

Relation of smoking and endothelial dysfunction markers in systemic hypertension
by: V. I. Podzolkov, et al.
Published: (2018-10-01)